Therapy of macroglobulinaemia. Comparison of the effect of therapy on the level of monoclonal immunoglobulins and on clinical symptoms in four cases of waldenström's macroglobulinaemia and one case of IgA myeloma.
D000362:Agar; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000188:drug therapy; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001796:Blood Protein Disorders / Q000175:diagnosis / Q000188:drug therapy*; D001809:Blood Viscosity / Q000187:drug effects; D002699:Chlorambucil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004586:Electrophoresis; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*; D005719:gamma-Globulins / Q000032:analysis
D000477:Alkylating Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D005719:gamma-Globulins; D002699:Chlorambucil; D000362:Agar; D011241:Prednisone